|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan 10617
2 Department of Chemical and Biochemical Engineering, University of Maryland, Baltimore, Maryland 21250, USA
3 Department of Chemical Engineering, Texas A&M University, College Station, Texas 77843-3122, USA
(RECEIVED November 22, 2004; FINAL REVISION February 23, 2005; ACCEPTED March 9, 2005)
Calcitonin, a peptide hormone associated with medullary carcinoma of the thyroid, has the potential to form amyloid fibrils and may be a valuable model for investigating the role of peptidemembrane interactions in
-sheet and amyloid formation. Via a new model peptide system, bovine calcitonin, we found that the exposure of peptide to phospholipid membranes altered its structure relative to the structures formed in aqueous solutions. Of particular relevance to the amyloidoses, incubation of calcitonin with cholesterol-rich and ganglioside-containing membranes resulted in significant enrichment in the
-sheet and amyloid content of the peptide. The formation of amyloid was also accelerated in these systems. A correlation between the phospholipid-induced structural alterations and calcitonin binding affinities to phospholipid membranes was evident. Bovine calcitonin has considerably higher binding affinity for the phospholipid systems that enhanced its
-sheet and amyloid structure. Electrostatic forces were not the governing forces behind the observed behavior, as supported by the fact that the ionic strength did not affect the peptide structures or binding affinities. A Vant Hoff analysis of the temperature-dependent peptide binding affinities indicated that binding led to an increase in enthalpy and possibly increase in entropy of the peptidemembrane systems. Experiments with other amyloid-forming peptides such as
-amyloid of Alzheimers disease have also shown similar results and may indicate the need to manipulate peptidemembrane interactions in order to control amyloid formation and its associated disease.
Keywords: secondary structure; amyloid; calcitonin; phospholipid membranes
Abbreviations: A
,
-amyloid CD, circular dichroism DPPC, 1,2-dipalmytoyl-sn-glycero-3-phosphocholine DOPS, 1,2-dioleoyl-sn-glycero-3-[phospho-L-serine] DPPE, 1,2-dipalmytoyl-sn-glycero-3-phosphoethanolamine DMPG, dimyristoylphosphatidylglycerol HFIP, 1,1,1,3,3,3-hexafluoro-2-propanol PBS, phosphate buffered saline TFA, trifluoroactic acid TFE, 1,1,1-trifluoroethanol
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041240105.
Reprint requests to: Steven S.-S. Wang, Department of Chemical Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, Taiwan 10617; e-mail: sswang{at}ntu.edu.tw; fax: +011-886-2-2362-3040.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
X. Luo, D. Sharma, H. Inouye, D. Lee, R. L. Avila, M. Salmona, and D. A. Kirschner Cytoplasmic Domain of Human Myelin Protein Zero Likely Folded as {beta}-Structure in Compact Myelin Biophys. J., March 1, 2007; 92(5): 1585 - 1597. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |